Astra-Oxford Vaccine Stays Near Front of Line Despite U.S. Delay

Bookmark
(Bloomberg) -- A seven-week halt to a U.S. trial of the Covid vaccine developed by AstraZeneca Plc and the University of Oxford bumped it from pole position in the race for a protective shot, but i...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.